| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,306 |
5,003 |
$2.48M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,647 |
7,155 |
$557K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,962 |
1,848 |
$288K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,762 |
3,563 |
$152K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,318 |
1,273 |
$126K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,044 |
4,782 |
$91K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
741 |
687 |
$58K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
347 |
324 |
$48K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,662 |
1,585 |
$42K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
653 |
606 |
$38K |
| 80053 |
Comprehensive metabolic panel |
4,293 |
3,789 |
$36K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,161 |
4,476 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
703 |
658 |
$30K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
700 |
655 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,365 |
1,212 |
$29K |
| 80074 |
|
480 |
435 |
$25K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
180 |
158 |
$24K |
| 86850 |
|
601 |
553 |
$23K |
| 81003 |
|
7,202 |
4,882 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
694 |
640 |
$20K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
120 |
106 |
$19K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,121 |
2,927 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
330 |
274 |
$15K |
| 87428 |
|
262 |
254 |
$15K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,622 |
2,734 |
$15K |
| 87632 |
|
47 |
41 |
$14K |
| 84703 |
|
1,368 |
1,238 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,163 |
1,030 |
$12K |
| 71045 |
Radiologic examination, chest; single view |
421 |
378 |
$11K |
| 85027 |
|
1,157 |
1,100 |
$10K |
| 86762 |
|
552 |
504 |
$9K |
| 84702 |
|
720 |
612 |
$9K |
| 86787 |
|
551 |
503 |
$8K |
| 59025 |
Fetal non-stress test |
54 |
44 |
$8K |
| 81001 |
|
2,486 |
2,241 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
108 |
86 |
$7K |
| 87653 |
|
126 |
122 |
$6K |
| 0001A |
|
332 |
326 |
$5K |
| 0002A |
|
352 |
348 |
$5K |
| 87081 |
|
465 |
440 |
$4K |
| 59430 |
|
26 |
26 |
$4K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
108 |
104 |
$4K |
| 86780 |
|
200 |
182 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
469 |
458 |
$3K |
| 86592 |
|
544 |
503 |
$3K |
| 86901 |
|
627 |
575 |
$2K |
| 86900 |
|
626 |
575 |
$2K |
| 92567 |
|
40 |
39 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
24 |
24 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
227 |
195 |
$2K |
| 83690 |
|
664 |
567 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
538 |
529 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,908 |
4,918 |
$2K |
| 87210 |
|
160 |
145 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$1K |
| 86803 |
|
51 |
47 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24 |
24 |
$1K |
| 82950 |
|
143 |
135 |
$860.21 |
| 70450 |
Computed tomography, head or brain; without contrast material |
25 |
24 |
$813.99 |
| 84484 |
|
544 |
462 |
$781.11 |
| 90715 |
|
32 |
29 |
$779.36 |
| 87340 |
|
50 |
47 |
$675.10 |
| 83880 |
|
84 |
80 |
$612.41 |
| 80061 |
Lipid panel |
504 |
499 |
$597.59 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
211 |
193 |
$565.75 |
| 90686 |
|
61 |
57 |
$419.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
244 |
188 |
$415.22 |
| 87430 |
|
15 |
15 |
$336.54 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
145 |
124 |
$280.35 |
| 85610 |
|
261 |
211 |
$251.32 |
| 90656 |
|
24 |
24 |
$175.77 |
| 83735 |
|
200 |
175 |
$162.64 |
| 81025 |
|
14 |
13 |
$113.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
202 |
164 |
$56.59 |
| 83605 |
|
16 |
13 |
$31.70 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$22.64 |
| 84439 |
|
13 |
13 |
$12.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
20 |
15 |
$11.59 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
898 |
675 |
$0.01 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
29 |
25 |
$0.00 |